只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-22 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 47,250 | US$29.77 | US$140.66万 | 26,529,686 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 21,696 | US$27.96 | US$606,620.16 | 26,438,209 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 6,504 | US$29.17 | US$189,721.68 | 26,444,713 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-21 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 37,723 | US$30.00 | US$113.17万 | 26,482,436 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 98,433 | US$27.13 | US$267.05万 | 26,383,526 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-07-20 2026-07-22 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 32,987 | US$27.72 | US$914,399.64 | 26,416,513 | SEC |
| 2026-06-15 2026-06-16 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 4,065 | US$27.10 | US$110,161.50 | 30,000 | SEC |
| 2026-06-15 2026-06-16 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 5,000 | US$26.00 | US$130,000.00 | 25,935 | SEC |
| 2026-06-12 2026-06-16 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 8,435 | US$27.67 | US$233,396.45 | 20,935 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital Group, LLC TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital Management, L.P. TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus PE GP III, LLC TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Private Equity GP III, LLC TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus GP, LLC TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Private Equity Fund III, L.P. TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital, LLC TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Levy Guy TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital Master Fund, L.P. TenPercentOwner | 买入（P） | 125,000 | US$20.00 | US$250万 | 652,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital Group, LLC TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital Management, L.P. TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus PE GP III, LLC TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Private Equity GP III, LLC TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus GP, LLC TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Private Equity Fund III, L.P. TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital, LLC TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Levy Guy TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-29 | PBLS Parabilis Medicines, Inc. | Soleus Capital Master Fund, L.P. TenPercentOwner | 买入（P） | 375,000 | US$20.00 | US$750万 | 1,027,000 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 12,500 | US$20.00 | US$250,000.00 | 12,500 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 19,728,353 | US$20.00 | US$3.95亿 | 26,285,093 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 19,728,353 | US$20.00 | US$3.95亿 | 26,285,093 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 19,728,353 | US$20.00 | US$3.95亿 | 26,285,093 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 19,728,353 | US$20.00 | US$3.95亿 | 26,285,093 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 19,728,353 | US$20.00 | US$3.95亿 | 26,285,093 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 1,460,397 | US$20.00 | US$2920.79万 | 2,648,278 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 1,460,397 | US$20.00 | US$2920.79万 | 2,648,278 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 1,460,397 | US$20.00 | US$2920.79万 | 2,648,278 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 1,460,397 | US$20.00 | US$2920.79万 | 2,648,278 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 1,460,397 | US$20.00 | US$2920.79万 | 2,648,278 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PBLS | 109,220.5246 | 0 | 137,699.0795 | 79.32% | B, Q, N |